Via International Business Times :
" The U.S. Food and Drug Administration (FDA) has approved the first test to help diagnose people with signs and symptoms of dengue fever or dengue hemorrhagic fever.
Manufactured by Seattle-based Inbios Inc., the DENV Detect IgM Capture ELISA test detects antibodies to dengue virus in blood samples from patients who have signs and symptoms of dengue.
According to the U.S. Centers for Disease Control and Prevention (CDC), as many as 100 million people worldwide are infected by the virus each year. The dengue virus is transmitted to humans by the bite of an infected Aedes mosquito."
No comments:
Post a Comment